Spine Biologics Global Market Analysis, Trends, Growth, Research And Forecast 2033

The new report published by The Business Research Company, titled "Spine Biologics Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the spine biologics market size has grown strongly in recent years. It will grow from $2.24 billion in 2023 to $2.36 billion in 2024 at a compound annual growth rate (CAGR) of 5.3%. The spine biologics market size is expected to see strong growth in the next few years. It will grow to $2.91 billion in 2028 at a compound annual growth rate (CAGR) of 5.4%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=15928&type=smp

Rising Number Of Road Accidents Drives The Growth Of Spinal Biologics Market
The rising number of road accidents is expected to propel the growth of the spinal biologics market going forward. A road accident refers to an unintended and unforeseen event involving one or more vehicles on a public road that often results in severe spinal injuries, necessitating advanced medical interventions for effective treatment and recovery. Road accidents are on the rise globally due to a variety of factors, such as distracted driving, an increase in traffic volume, poor road conditions and infrastructure, and alcohol and drug impairment. Spine biologics serve an essential role in improving patient outcomes by boosting spinal fusion, speeding healing, lowering surgical risks, enhancing pain management, and decreasing the need for revision operations. For instance, in May 2022, according to the National Highway Traffic Safety Administration, a US-based government agency, an estimated 42,915 people died in motor vehicle traffic crashes last year in the US, marking a 10.5% rise from the 38,824 fatalities in 2020. Therefore, the rising number of road accidents is driving the growth of the spinal biologics market.

Innovative Synthetic Bioactive Bone Graft For Spinal Fusion Procedures
Major companies operating in the spinal biologics market are developing advanced products, such as synthetic bioactive bone grafts, to better serve patients and gain a competitive edge in the market. Synthetic bioactive bone graft refers to a man-made spine biologic engineered to support and enhance bone growth and healing in spinal fusion surgeries. For instance, in February 2022, Orthofix Medical Inc., a US-based spine and orthopedics company, launched Opus BA, a synthetic bioactive bone graft for cervical and lumbar spine fusion procedures. It is offered in putty and strip forms and acts as a scaffold for bone growth, which is reabsorbed and replaced by natural bone. It can be hydrated with autogenous bone marrow or autografted with saline. Opus BA features an osteoconductive matrix made from carbonate apatite bone mineral, bioactive glass, and Type 1 collagen, stimulating bone growth and resorption.

The spine biologics market covered in this report is segmented -

1) By Product: Bone Allografts, Bone Graft Substitute, Platelet Rich Plasma, Bone Marrow Aspirate Therapy
2) By Surgery Type: Anterior Cervical Discectomy And Fusion (ACDF), Posterior Lumbar Interbody Fusion (PLIF), Transforaminal Lumbar Interbody Fusion (TLIF), Anterior Lumbar Interbody Fusion (ALIF), Lateral Lumbar Interbody Fusion (LLIF), Other Surgery Types
3) By Application: Spinal Fusion, Spinal Non-Union And Fracture Repair, Degenerative Disc Disease Treatment, Other Applications
4) By End User: Hospitals, Spinal Surgery Centers, Orthopedic Clinics, Other End Users

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=15928&type=discount

Major companies operating in the spine biologics market are Johnson & Johnson Services Inc., Medtronic PLC, Stryker Corporation, Baxter International Inc., B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Arthrex Inc., Integra LifeSciences Corporation, Bone Biologics Corp., InVivo Therapeutics Corp., RTI Surgical Inc., Paragon 28 Inc., LifeNet Health Inc., Xtant Medical Holdings Inc., Kuros Biosciences A.G., CoreLink LLC , Spinal Elements Inc., Life Spine Inc., Innovasis Inc., Camber Spine Technologies LLC, SurGenTec LLC, ChoiceSpine LLC, Cerapedics Inc, Aziyo Biologics, Amedica Corporation

Contents of the report:
1. Executive Summary
2. Spine Biologics Market Report Structure
3. Spine Biologics Market Trends And Strategies
4. Spine Biologics Market - Macro Economic Scenario
5. Spine Biologics Market Size And Growth
…..
27. Spine Biologics Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/spine-biologics-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.